Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Product: Trevicta
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Trevicta 350mg/1.75ml prolonged-release inj pf syringes
0402020ABBCACAH
|
Trevicta | Paliperidone | Central Nervous System | 59 |
|
Trevicta 525mg/2.625ml prolonged-release inj pf syringes
0402020ABBCADAI
|
Trevicta | Paliperidone | Central Nervous System | 43 |
|
Trevicta 263mg/1.315ml prolonged-release inj pf syringes
0402020ABBCABAG
|
Trevicta | Paliperidone | Central Nervous System | 16 |
|
Trevicta 175mg/0.875ml prolonged-release inj pf syringes
0402020ABBCAAAF
|
Trevicta | Paliperidone | Central Nervous System | 15 |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.